{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:31Z","timestamp":1792515751841,"version":"4.5.0"},"reference-count":46,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T044594\/1"],"award-info":[{"award-number":["MR\/T044594\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR134670"],"award-info":[{"award-number":["NIHR134670"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,7,3]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>For surveillance for hepatocellular carcinoma (HCC) to be effective, tests\u2014including imaging, serological biomarkers (conventional and genomic) and algorithms combining multiple tests\u2014must identify early-stage tumours. We aimed to identify, appraise and synthesise studies reporting the accuracy of all such tests in people with cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and network meta-analysis of diagnostic test accuracy (NMA-DTA) data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>MEDLINE and Embase (2005 to September 2025) and a published Cochrane review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>English-language, post-2005, one-gate or two-gate studies quantifying diagnostic accuracy of tests to detect HCC in populations wholly comprising people with cirrhosis, excluding those with pre-existing signs and symptoms of HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Data extracted by one reviewer, checked by a second and made available in an open-access database. We assessed risk of bias using QUADAS-2. We synthesised data using Bayesian NMA-DTA, accounting for tumour stage and incorporating continuous tests across all possible thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 170 studies (62\u2009643 participants). Of 115 index tests, 97 were amenable to NMA-DTA. Ultrasound appears no better than alpha-fetoprotein at detecting very-early-stage HCC (sensitivity 0.34 (95% CrI 0.21 to 0.55)\u2009vs 0.39 (95% CrI 0.28 to 0.47)), only becoming superior as stage advances. Least affected by stage are contrast-enhanced MRI (sensitivity 0.70 (95% CrI 0.50 to 0.84)\u2009very-early; 0.86 (95% CrI 0.73 to 0.94)\u2009early; 0.90 (95% CrI 0.67 to 0.98) advanced) and CT (0.68 (95% CrI 0.26 to 0.93)\u2009very-early; 0.77 (95% CrI 0.29 to 0.95) early; 0.92 (95% CrI 0.49 to 0.99) advanced). No genomic biomarkers show convincing improvements over combinations of conventional blood-markers. Most studies are at high risk of bias, but conclusions are robust when restricting to studies with favourable methodological characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using advanced synthesis methods, we found that tests have low sensitivity for detecting early-stage HCC. Given rising prevalence of cirrhosis and HCC, we need better tests and a stronger evidence-base to inform optimal surveillance strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42022357163.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2025-002155","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:40:20Z","timestamp":1784288420000},"page":"e002155","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9339-7374","authenticated-orcid":false,"given":"Gabriel","family":"Rogers","sequence":"first","affiliation":[{"name":"Manchester Centre for Health Economics, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-8445","authenticated-orcid":false,"given":"Efthymia","family":"Derezea","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libby","family":"Sadler","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E","family":"Cramp","sequence":"additional","affiliation":[{"name":"Peninsula Medical School, University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Ryder","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0280-2483","authenticated-orcid":false,"given":"Kelsey","family":"Watt","sequence":"additional","affiliation":[{"name":"Aneurin Bevan University Health Board, Newport, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Whiting","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morwenna","family":"Rogers","sequence":"additional","affiliation":[{"name":"Medical School, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bell","sequence":"additional","affiliation":[{"name":"Patient representative, NA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Oppe","sequence":"additional","affiliation":[{"name":"Patient representative, NA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Stein","sequence":"additional","affiliation":[{"name":"Medical School, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-3205","authenticated-orcid":false,"given":"Nicky J","family":"Welton","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-2854","authenticated-orcid":false,"given":"Hayley E","family":"Jones","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026071704401674000_13.1.e002155.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.08.011"},{"key":"2026071704401674000_13.1.e002155.2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466"},{"key":"2026071704401674000_13.1.e002155.3","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13892"},{"key":"2026071704401674000_13.1.e002155.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.028"},{"key":"2026071704401674000_13.1.e002155.5","unstructured":"National Institute for Health and Care Excellence . Cirrhosis in over 16s: Assessment and Management (NG50). London, 2016. Available: https:\/\/www.nice.org.uk\/guidance\/ng50"},{"key":"2026071704401674000_13.1.e002155.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00620-y"},{"key":"2026071704401674000_13.1.e002155.7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2015","journal-title":"Radiology"},{"key":"2026071704401674000_13.1.e002155.8","doi-asserted-by":"crossref","first-page":"109404","DOI":"10.1016\/j.ejrad.2020.109404","article-title":"Diagnostic performance of LI-RADS for MRI and CT detection of HCC: a systematic review and diagnostic meta-analysis","volume":"134","author":"Liang","year":"2021","journal-title":"Eur J Radiol"},{"key":"2026071704401674000_13.1.e002155.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.041"},{"key":"2026071704401674000_13.1.e002155.10","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1007\/s00261-021-03248-9","article-title":"Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma","volume":"46","author":"Hai","year":"2021","journal-title":"Abdom Radiol"},{"key":"2026071704401674000_13.1.e002155.11","article-title":"Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease","volume":"4","author":"Colli","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026071704401674000_13.1.e002155.12","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/hep4.2045","article-title":"Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis","volume":"6","author":"Singal","year":"2022","journal-title":"Hepatol Commun"},{"key":"2026071704401674000_13.1.e002155.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.064"},{"key":"2026071704401674000_13.1.e002155.14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cam4.2799","article-title":"Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: a systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med"},{"key":"2026071704401674000_13.1.e002155.15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jrsm.1700","article-title":"Twenty years of network meta-analysis: continuing controversies and recent developments","volume":"15","author":"Ades","year":"2024","journal-title":"Res Synth Methods"},{"key":"2026071704401674000_13.1.e002155.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.02.001"},{"key":"2026071704401674000_13.1.e002155.17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3310\/nihropenres.13409.1","article-title":"Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocol","volume":"3","author":"Sadler","year":"2023","journal-title":"NIHR Open Res"},{"key":"2026071704401674000_13.1.e002155.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m2632","article-title":"Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist","volume":"370","author":"Salameh","year":"2020","journal-title":"BMJ"},{"key":"2026071704401674000_13.1.e002155.19","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.048595"},{"key":"2026071704401674000_13.1.e002155.20","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2026071704401674000_13.1.e002155.21","doi-asserted-by":"publisher","DOI":"10.7326\/M21-2234"},{"key":"2026071704401674000_13.1.e002155.22","first-page":"1","article-title":"JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling","volume":"124","author":"Plummer","year":"2003","journal-title":"Proc 3rd Int Workshop Distrib Stat Comput"},{"key":"2026071704401674000_13.1.e002155.23","unstructured":"Su YS , Yajima M . R2jags: using R to run \"JAGS\". 2024 Available: https:\/\/CRAN.R-project.org\/package=R2jags"},{"key":"2026071704401674000_13.1.e002155.24","unstructured":"R Core Team . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2024. Available: https:\/\/www.R-project.org\/"},{"key":"2026071704401674000_13.1.e002155.25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","volume":"7","author":"Gelman","year":"1992","journal-title":"Statist Sci"},{"key":"2026071704401674000_13.1.e002155.26","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669182"},{"key":"2026071704401674000_13.1.e002155.27","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1002\/sim.8301","article-title":"Quantifying how diagnostic test accuracy depends on threshold in a meta-analysis","volume":"38","author":"Jones","year":"2019","journal-title":"Stat Med"},{"key":"2026071704401674000_13.1.e002155.28","unstructured":"Derezea E , Rogers G , Welton NJ , et al . Meta-analysis of networks of diagnostic tests with binary and continuous results. arxiv. 2026. Available: http:\/\/arxiv.org\/abs\/2604.19996"},{"key":"2026071704401674000_13.1.e002155.29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.942"},{"key":"2026071704401674000_13.1.e002155.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.06.011"},{"key":"2026071704401674000_13.1.e002155.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.02.022"},{"key":"2026071704401674000_13.1.e002155.32","unstructured":"Derezea E , Welton NJ , Rogers G , et al . Meta-analysis of diagnostic test accuracy with multiple disease stages: combining stage-specific and merged-stage data. arXiv. 2026. Available: http:\/\/arxiv.org\/abs\/2512.12065"},{"key":"2026071704401674000_13.1.e002155.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.11.1061"},{"key":"2026071704401674000_13.1.e002155.34","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24296","article-title":"Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis","volume":"36","author":"Qian","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"2026071704401674000_13.1.e002155.35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.31557\/APJCP.2021.22.6.1731","article-title":"Clinical utility of protein induced by vitamin K absence-II in patients with hepatocellular carcinoma","volume":"22","author":"Bhatti","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026071704401674000_13.1.e002155.36","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2565"},{"key":"2026071704401674000_13.1.e002155.37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/HEP.0000000000000953","article-title":"HES V2.0 outperforms GALAD for detection of HCC: a phase 3 biomarker study in the United States","volume":"81","author":"El-Serag","year":"2025","journal-title":"Hepatology"},{"key":"2026071704401674000_13.1.e002155.38","first-page":"44","article-title":"Usefulness of alpha-fetoprotein as circulating immune complexes (AFP-IC) in the diagnosis of hepatocellular carcinoma in cirrhotic patients","volume":"7","author":"Krygier","year":"2011","journal-title":"Exp Clin Hepatol"},{"key":"2026071704401674000_13.1.e002155.39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.cgh.2013.09.053","article-title":"Factors that affect accuracy of \u03b1-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis","volume":"12","author":"Gopal","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2026071704401674000_13.1.e002155.40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2024.04.007","article-title":"EASL position paper on clinical follow-up after HCV cure","volume":"81","author":"Reiberger","year":"2024","journal-title":"J Hepatol"},{"key":"2026071704401674000_13.1.e002155.41","article-title":"Comparison of the accuracy of DWI and ultrasonography in screening hepatocellular carcinoma in patients with chronic liver disease","volume":"12","author":"Jalli","year":"2015","journal-title":"Iran J Radiol"},{"key":"2026071704401674000_13.1.e002155.42","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000264","article-title":"Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe","volume":"7","author":"Beudeker","year":"2023","journal-title":"Hepatol Commun"},{"key":"2026071704401674000_13.1.e002155.43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2024.09.008","article-title":"A phase 3 biomarker validation of GALAD for the detection of hepatocellular carcinoma in cirrhosis","volume":"168","author":"Marsh","year":"2025","journal-title":"Gastroenterology"},{"key":"2026071704401674000_13.1.e002155.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.01.047"},{"key":"2026071704401674000_13.1.e002155.45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24581"},{"key":"2026071704401674000_13.1.e002155.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.08.010"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2025-002155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:40:27Z","timestamp":1784288427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2025-002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjgast-2025-002155"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2025-002155","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}